Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Clinical trial NCT01691313 · COMPLETED
Trial details
- NCT number
- NCT01691313
- Sponsor
- Laguna Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.